| # | Drug | Count |
|---|---|---|
| 0 | MOXIFLOXACIN HYDROCHLORIDE | 7 |
| 1 | MOXIFLOXACIN | 4 |
| 2 | BESIFLOXACIN | 3 |
| 3 | LOTEPREDNOL ETABONATE | 3 |
| 4 | BALANCED SALT SOLUTION | 2 |
| 5 | CARBOPLATIN | 2 |
| 6 | ETOPOSIDE | 2 |
| 7 | TOBRAMYCIN | 2 |
| 8 | TOBRAMYCIN SOLUTION | 2 |
| 9 | TOBRAMYCIN SULFATE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BESIFLOXACIN | 3 | 0.0031 |
| 1 | BALANCED SALT SOLUTION | 2 | 0.0015 |
| 2 | CEFUROXIME SODIUM | 1 | 0.0008 |
| 3 | COLISTIMETHATE SODIUM | 1 | 0.0006 |
| 4 | LOTEPREDNOL ETABONATE | 3 | 0.0006 |
| 5 | MOXIFLOXACIN HYDROCHLORIDE | 7 | 0.0003 |
| 6 | FLUOROMETHOLONE | 1 | 0.0003 |
| 7 | CARBOXYMETHYLCELLULOSE SODIUM | 1 | 0.0002 |
| 8 | TOBRAMYCIN SOLUTION | 2 | 0.0002 |
| 9 | TOBRAMYCIN SULFATE | 2 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Quinolone Antimicrobial [EPC] | 4 |
| 1 | Corticosteroid [EPC] | 3 |
| 2 | Aminoglycoside Antibacterial [EPC] | 2 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 2 |
| 4 | Platinum-based Drug [EPC] | 2 |
| 5 | Topoisomerase Inhibitor [EPC] | 2 |
| 6 | Amide Local Anesthetic [EPC] | 1 |
| 7 | Antiarrhythmic [EPC] | 1 |
| 8 | Anticholinergic [EPC] | 1 |
| 9 | Azole Antifungal [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Quinolone Antimicrobial [EPC] | 4 | 0.0004 |
| 1 | Anticholinergic [EPC] | 1 | 0.0001 |
| 2 | Aminoglycoside Antibacterial [EPC] | 2 | 0.0000 |
| 3 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Topoisomerase Inhibitor [EPC] | 2 | 0.0000 |
| 5 | Cholinergic Muscarinic Antagonist [EPC] | 1 | 0.0000 |
| 6 | Ester Local Anesthetic [EPC] | 1 | 0.0000 |
| 7 | Nitroimidazole Antimicrobial [EPC] | 1 | 0.0000 |
| 8 | Tetracycline-class Drug [EPC] | 1 | 0.0000 |
| 9 | Non-Standardized Chemical Allergen [EPC] | 1 | 0.0000 |